| R&D SYSTEMS 产品目录--泽浩公司 |
| R&D SYSTEMS 产品目录列表 page 4 >> 1 2 3 4 5 6 7 8 9 10 >>..More |
| 产品编号 |
产品描述 |
规格/包装 |
品牌 |
| 2910-AP-010 |
Recombinant Mouse Alkaline Phosphatase/ALPL, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 2914-HT-001G |
Human Holo-Transferrin, CF (1 G) |
1 G |
R&D SYSTEMS |
| 2914-HT-100MG |
Human Holo-Transferrin, CF (100 MG) |
100 MG |
R&D SYSTEMS |
| 2915-IL-025 |
Recombinant Mouse IL-19 (25 UG) |
25 UG |
R&D SYSTEMS |
| 2915-IL-025/CF |
Recombinant Mouse IL-19, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 2918-SD-050 |
Recombinant Human Syndecan-4, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 291-G1-050 |
Recombinant Human IGF-I/IGF-1, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 291-G1-250 |
Recombinant Human IGF-I/IGF-1, CF (250 UG) |
250 UG |
R&D SYSTEMS |
| 2926-BP-025 |
Recombinant Human BMP-10 (25 UG) |
25 UG |
R&D SYSTEMS |
| 2926-BP-025/CF |
Recombinant Human BMP-10, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 2929-TM-050 |
Recombinant Human TIM-4, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 292-G2-050 |
Recombinant Human IGF-II, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 292-G2-250 |
Recombinant Human IGF-II, CF (250 UG) |
250 UG |
R&D SYSTEMS |
| 2930-K2-050 |
Recombinant Mouse Kirrel2, CF |
50 µg |
R&D SYSTEMS |
| 2934-ST-050 |
Recombinant Mouse Sortilin, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2939-CA-010 |
Recombinant Human Carbonic Anhydrase VI, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 293-VE-010 |
Recombinant Human VEGF 165 (10 UG) |
10 UG |
R&D SYSTEMS |
| 293-VE-010/CF |
Recombinant Human VEGF 165, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 293-VE-050 |
Recombinant Human VEGF 165 (50 UG) |
50 UG |
R&D SYSTEMS |
| 293-VE-050/CF |
Recombinant Human VEGF 165, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2940-CM-050 |
Recombinant Human CMG-2, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2947-CL-050 |
Recombinant Human LSECtin/CLEC4G, CF |
50 µg |
R&D SYSTEMS |
| 2949-MC-050 |
Recombinant Mouse Mimecan, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 294-HG-005 |
Recombinant Human HGF (5 UG) |
5 UG |
R&D SYSTEMS |
| 294-HG-005/CF |
Recombinant Human HGF, CF (5 UG) |
5 UG |
R&D SYSTEMS |
| 294-HG-025 |
Recombinant Human HGF (25 UG) |
25 UG |
R&D SYSTEMS |
| 294-HG-025/CF |
Recombinant Human HGF, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 294-HGN-005 |
Recombinant Human HGF (NS0-expressed) (5 UG) |
5 UG |
R&D SYSTEMS |
| 294-HGN-005/CF |
Recombinant Human HGF (NS0-expressed), CF (5 UG) |
5 UG |
R&D SYSTEMS |
| 294-HGN-025 |
Recombinant Human HGF (NS0-expressed) (25 UG) |
25 UG |
R&D SYSTEMS |
| 294-HGN-025/CF |
Recombinant Human HGF (NS0-expressed), CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 2955-F2-050 |
Recombinant Mouse OSF-2/Periostin, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2956-MA-050 |
Recombinant Mouse MARCO, CF |
50 µg |
R&D SYSTEMS |
| 2956-MA-050 |
Recombinant Mouse MARCO, CF |
50 µg |
R&D SYSTEMS |
| 295-OM-010 |
Recombinant Human Oncostatin M (OSM) (10 UG) |
10 UG |
R&D SYSTEMS |
| 295-OM-010/CF |
Recombinant Human Oncostatin M (OSM), CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 295-OM-050 |
Recombinant Human Oncostatin M (OSM) (50 UG) |
50 UG |
R&D SYSTEMS |
| 295-OM-050/CF |
Recombinant Human Oncostatin M (OSM), CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2960-LR-025 |
Recombinant Mouse LRP-6, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 2965-SD-050 |
Recombinant Human Syndecan-2, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2967-MP-010 |
Recombinant Mouse MMP-7, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 2968-SE-010 |
Recombinant Mouse Prostasin/Prss8, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 2969-SU-020 |
Recombinant Mouse Sulfamidase/SGSH, CF (20 UG) |
20 UG |
R&D SYSTEMS |
| 296-HR-050 |
Recombinant Human NRG1-alpha/HRG1-alpha EGF Domain (50 UG) |
50 UG |
R&D SYSTEMS |
| 296-HR-050/CF |
Recombinant Human NRG1-alpha/HRG1-alpha EGF Domain, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2970-ZN-010 |
Recombinant Human Aminopeptidase P1/XPNPEP1, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 2974-PI-010 |
Recombinant Human TFPI, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 2975-PI-010 |
Recombinant Mouse TFPI, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 2976-AS-050 |
Recombinant Mouse BACE-1, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 2977-AS-020 |
Recombinant Mouse BACE-2, CF (20 UG) |
20 UG |
R&D SYSTEMS |
| 2978-AD-010 |
Recombinant Mouse TACE/ADAM17, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 2979-PI-010 |
Recombinant Mouse Serpin A1/alpha-1-Antitrypsin, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 297-VP-005 |
Recombinant Human VEGF/PlGF Heterodimer (5 UG) |
5 UG |
R&D SYSTEMS |
| 297-VP-005/CF |
Recombinant Human VEGF/PlGF Heterodimer, CF (5 UG) |
5 UG |
R&D SYSTEMS |
| 2980-PI-010 |
Recombinant Human Serpin E2/PN1, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 2984-SE-010 |
Recombinant Human Proprotein Convertase 7/PCSK7, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 2985-ZN-010 |
Recombinant Mouse TRH-degrading Ectoenzyme/TRHDE, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 298-VS-005 |
Recombinant Human VEGF 121 (5 UG) |
5 UG |
R&D SYSTEMS |
| 298-VS-005/CF |
Recombinant Human VEGF 121, CF (5 UG) |
5 UG |
R&D SYSTEMS |
| 298-VS-025 |
Recombinant Human VEGF 121 (25 UG) |
25 UG |
R&D SYSTEMS |
| 298-VS-025/CF |
Recombinant Human VEGF 121, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 299-LT-005 |
Recombinant Human Latent TGF-beta 1 (5 UG) |
5 UG |
R&D SYSTEMS |
| 299-LT-005/CF |
Recombinant Human Latent TGF-beta 1, CF (5 UG) |
5 UG |
R&D SYSTEMS |
| 299-LT-025 |
Recombinant Human Latent TGF-beta 1 (25 UG) |
25 UG |
R&D SYSTEMS |
| 299-LT-025/CF |
Recombinant Human Latent TGF-beta 1, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 2ZH3925H |
Human ROR MAb (Clone H3925) |
100 UG |
R&D SYSTEMS |
| 2ZH4537H |
Human VDR/NR1I1 MAb (Clone H4537) |
100 UG |
R&D SYSTEMS |
| 2ZH6437H |
Human ROR gamma/NR1F3 MAb (Clone H6437) |
100 UG |
R&D SYSTEMS |
| 2ZH6812H |
Human ERR gamma/NR3B3 MAb (Clone H6812) |
100 UG |
R&D SYSTEMS |
| 2ZH7507H |
Human Androgen R/NR3C4 MAb (Clone H7507) |
100 UG |
R&D SYSTEMS |
| 2ZH7833H |
Human NGFI-B gamma/NOR-1/NR4A3 MAb (Clone H7833) |
100 UG |
R&D SYSTEMS |
| 2ZH8031H |
Human GR/NR3C1 MAb (Clone H8031) |
100 UG |
R&D SYSTEMS |
| 2ZK8801H |
Human LRH-1/NR5A2 MAb (Clone K8801) |
100 UG |
R&D SYSTEMS |
| 2ZK9218H |
Human HNF-4 alpha 1-6/NR2A1 MAb (Clone K9218) |
100 UG |
R&D SYSTEMS |
| 2ZK9814H |
Human SALL1 MAb (Clone K9814) |
100 UG |
R&D SYSTEMS |
| 2ZPPJ0069H |
Human Pentraxin 3/TSG-14 MAb (Clone PPJ0069) |
100 UG |
R&D SYSTEMS |
| 2ZPPZ0506H |
Human ER beta/NR3A2 MAb (Clone PPZ0506) |
100 UG |
R&D SYSTEMS |
| 3005-TR-050 |
Recombinant Mouse TLR3, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 3006-WN-025 |
Recombinant Mouse Wnt-5b (25 UG) |
25 UG |
R&D SYSTEMS |
| 3006-WN-025/CF |
Recombinant Mouse Wnt-5b, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 3007-BT-050 |
Recombinant Mouse BTLA/Fc Chimera, CF |
50 µg |
R&D SYSTEMS |
| 3007-BT-050 |
Recombinant Mouse BTLA/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 3008-WN-025 |
Recombinant Human Wnt-7a (25 UG) |
25 UG |
R&D SYSTEMS |
| 3008-WN-025/CF |
Recombinant Human Wnt-7a, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 3009-SK-050 |
Recombinant Human SLITRK1, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 3014-NR-025 |
Recombinant Human Norrin, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 3017-MN-050 |
Recombinant Human Matrilin-3, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 301-R3-025 |
Recombinant Human IL-3 sR alpha (25 UG) |
25 UG |
R&D SYSTEMS |
| 301-R3-025/CF |
Recombinant Human IL-3 sR alpha, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 302-B2-002 |
Recombinant Human TGF-beta 2 (2 UG) |
2 UG |
R&D SYSTEMS |
| 302-B2-002/CF |
Recombinant Human TGF-beta 2, CF (2 UG) |
2 UG |
R&D SYSTEMS |
| 302-B2-010 |
Recombinant Human TGF-beta 2 (10 UG) |
10 UG |
R&D SYSTEMS |
| 302-B2-010/CF |
Recombinant Human TGF-beta 2, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 3030-CN-025 |
Recombinant Human Contactin-5, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 3034-A1-100 |
Recombinant Mouse EphA1, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 3035-A2-100 |
Recombinant Human EphA2, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 3036-A5-100 |
Recombinant Human EphA5, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 3037-A5-100 |
Recombinant Mouse EphA5, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 3038-B4-100 |
Recombinant Human EphB4, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 3039-AB-050 |
Recombinant Mouse IFN-alpha/beta R1, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 303-CR-050 |
Recombinant Human CNTF sR alpha (50 UG) |
50 UG |
R&D SYSTEMS |
| 303-CR-050/CF |
Recombinant Human CNTF sR alpha, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 3044-MN-050 |
Recombinant Human Matrilin-2 (50 UG) |
50 UG |
R&D SYSTEMS |
| 3044-MN-050/CF |
Recombinant Human Matrilin-2, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 3046-MB-025 |
Recombinant Human CCL4L1/MIP-1 beta Isoform LAG-1 (25 UG) |
25 UG |
R&D SYSTEMS |
| 3046-MB-025/CF |
Recombinant Human CCL4L1/MIP-1 beta Isoform LAG-1, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 3047-CC-050 |
Recombinant Human COCO (50 UG) |
50 UG |
R&D SYSTEMS |
| 3047-CC-050/CF |
Recombinant Human COCO, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 3048-VG-025 |
Recombinant Human VG5Q, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 3049-CA-010 |
Recombinant Human Carbonic Anhydrase VA, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 304-B3-001 |
Recombinant Human TGF-beta 1.2 (1 UG) |
1 UG |
R&D SYSTEMS |
| 304-B3-001/CF |
Recombinant Human TGF-beta 1.2, CF (1 UG) |
1 UG |
R&D SYSTEMS |
| 3050-AV-050 |
Recombinant Human Integrin alpha V beta 3, CF |
50 µg |
R&D SYSTEMS |
| 305-GR-050 |
Recombinant Human IGF-I sR (Histidine-tagged),(IGF-1 sR), CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 3064-N3-050 |
Recombinant Human Nectin-3, CF |
50 µg |
R&D SYSTEMS |
| 3067-SR-050 |
Recombinant Mouse SorCS3, CF |
50 µg |
R&D SYSTEMS |
| 3067-SR-050 |
Recombinant Mouse SorCS3, CF |
50 µg |
R&D SYSTEMS |
| 306-IR-050 |
Recombinant Human IL-7 R alpha/CD127/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 3074-TH-050 |
Recombinant Human Thrombospondin-1, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 3076-RB-050 |
Recombinant Human ROBO3/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 307-ER-050 |
Recombinant Human Erythropoietin sR (50 UG) |
50 UG |
R&D SYSTEMS |
| 307-ER-050/CF |
Recombinant Human Erythropoietin sR, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 308-FK-005 |
Recombinant Human Flt-3 Ligand (5 UG) |
5 UG |
R&D SYSTEMS |
| 308-FK-005/CF |
Recombinant Human Flt-3 Ligand, CF (5 UG) |
5 UG |
R&D SYSTEMS |
| 308-FK-025 |
Recombinant Human Flt-3 Ligand (25 UG) |
25 UG |
R&D SYSTEMS |
| 308-FK-025/CF |
Recombinant Human Flt-3 Ligand, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 308-FKN-005 |
Recombinant Human Flt-3 Ligand (NSO) (5 UG) |
5 UG |
R&D SYSTEMS |
| 308-FKN-005/CF |
Recombinant Human Flt-3 Ligand, CF (5 UG) |
5 UG |
R&D SYSTEMS |
| 308-FKN-025 |
Recombinant Human Flt-3 Ligand (NSO) (25 UG) |
25 UG |
R&D SYSTEMS |
| 308-FKN-025/CF |
Recombinant Human Flt-3 Ligand, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 3095-SE-010 |
Recombinant Human Kallikrein 12, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 3097-ZN-020 |
Thermolysin, CF (20 UG) |
20 UG |
R&D SYSTEMS |
| 309-IL-002 |
Recombinant Human IL-12/IL-23 p40 Monomer (2 UG) |
2 UG |
R&D SYSTEMS |
| 3104-PO-050 |
Recombinant Mouse Podocan, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 3105-DK-010 |
Recombinant Mouse Dkk-4 (10 UG) |
10 UG |
R&D SYSTEMS |
| 3105-DK-010/CF |
Recombinant Mouse Dkk-4, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 3106-AM-050 |
Recombinant Mouse AMICA/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 3107-RN-025 |
Recombinant Human Relaxin-3 (25 UG) |
25 UG |
R&D SYSTEMS |
| 3107-RN-025/CF |
Recombinant Human Relaxin-3, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 3114-DC-050 |
Recombinant Human Dectin-2/CLECSF10, CF |
50 µg |
R&D SYSTEMS |
| 3114-DC-050 |
Recombinant Human Dectin-2/CLECSF10, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 3130-CL-050 |
Recombinant Mouse CL-P1/COLEC12, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 3134-CP-050 |
Recombinant Human COMP, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 3135-SP-025 |
Recombinant Human F-Spondin (25 UG) |
25 UG |
R&D SYSTEMS |
| 3135-SP-025/CF |
Recombinant Human F-Spondin, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 3136-RL-010 |
Recombinant Rat IL-23 (10 UG) |
10 UG |
R&D SYSTEMS |
| 3136-RL-010/CF |
Recombinant Rat IL-23, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 3137-PL-010 |
Recombinant Porcine IL-5 (10 UG) |
10 UG |
R&D SYSTEMS |
| 3137-PL-010/CF |
Recombinant Porcine IL-5, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 3138-GN-025/CF |
Recombinant Human Granulysin, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 3139-FB-025 |
Recombinant Mouse FGF basic (25 UG) |
25 UG |
R&D SYSTEMS |
| 3139-FB-025/CF |
Recombinant Mouse FGF basic, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 313-TI-100 |
Recombinant Human Tie-2/Fc Chimera, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 3140-ME-050 |
Recombinant Human MEPE, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 3144-JE-025 |
Recombinant Rat CCL2/JE/MCP-1 (25 UG) |
25 UG |
R&D SYSTEMS |
| 3144-JE-025/CF |
Recombinant Rat CCL2/JE/MCP-1, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 3146-TM-050 |
Recombinant Human TLR4/MD-2 (50 UG) |
50 UG |
R&D SYSTEMS |
| 3146-TM-050/CF |
Recombinant Human TLR4/MD-2, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 3147-RB-050 |
Recombinant Human ROBO2/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 314-BP-010 |
Recombinant Human BMP-4 (10 UG) |
10 UG |
R&D SYSTEMS |
| 314-BP-010/CF |
Recombinant Human BMP-4, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 3154-ST-050 |
Recombinant Human Sortilin, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 3155-RB-050 |
Recombinant Mouse ROBO3/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 3159-NN-050 |
Recombinant Mouse Nephrin, CF |
50 µg |
R&D SYSTEMS |
| 315-BR-100 |
Recombinant Human BMPR-IA/ALK-3/Fc Chimera (100 UG) |
100 UG |
R&D SYSTEMS |
| 315-BR-100/CF |
Recombinant Human BMPR-IA/ALK-3/Fc Chimera, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 3160-CA-020 |
Recombinant Human Active Calcineurin, CF |
20 µg |
R&D SYSTEMS |
| 3160-CA-020 |
Recombinant Human Active Calcineurin, CF (20 UG) |
20 UG |
R&D SYSTEMS |
| 316-IL-002 |
Recombinant Human IL-16 (2 UG) |
2 UG |
R&D SYSTEMS |
| 316-IL-002/CF |
Recombinant Human IL-16, CF (2 UG) |
2 UG |
R&D SYSTEMS |
| 316-IL-025 |
Recombinant Human IL-16 (25 UG) |
25 UG |
R&D SYSTEMS |
| 316-IL-025/CF |
Recombinant Human IL-16, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 3174-MP-250 |
Recombinant Human Myeloperoxidase, CF |
250 µg |
R&D SYSTEMS |
| 3174-MP-250 |
Recombinant Human Myeloperoxidase, CF (250 UG) |
250 UG |
R&D SYSTEMS |
| 3176-CA-010 |
Recombinant Human Carbonic Anhydrase VB, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 3177-CA-050 |
Recombinant Human Carbonic Anhydrase VII, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 3178-PA-010 |
Recombinant Mouse Coagulation Factor III/Tissue Factor, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 317-IL-050 |
Recombinant Human IL-17 (50 UG) |
50 UG |
R&D SYSTEMS |
| 317-IL-050/CF |
Recombinant Human IL-17, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 3188-AT-001G |
Human Apo-Transferrin, CF (1 G) |
1 G |
R&D SYSTEMS |
| 3188-AT-100MG |
Human Apo-Transferrin, CF (100 MG) |
100 MG |
R&D SYSTEMS |
| 3198-PI-010 |
Recombinant Human Serpin D1/Heparin Cofactor II, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 319-FG-025 |
Recombinant Human FGF-17 (25 UG) |
25 UG |
R&D SYSTEMS |
| 319-FG-025/CF |
Recombinant Human FGF-17, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 3209-BP-010 |
Recombinant Human BMP-9 (10 UG) |
10 UG |
R&D SYSTEMS |
| 3209-BP-010/CF |
Recombinant Human BMP-9, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 320-EO-020 |
Recombinant Human CCL11/Eotaxin (20 UG) |
20 UG |
R&D SYSTEMS |
| 320-EO-020/CF |
Recombinant Human CCL11/Eotaxin, CF (20 UG) |
20 UG |
R&D SYSTEMS |
| 320-EO-100 |
Recombinant Human CCL11/Eotaxin (100 UG) |
100 UG |
R&D SYSTEMS |
| 320-EO-100/CF |
Recombinant Human CCL11/Eotaxin, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 3210-C-025 |
Recombinant Mouse CCL6/C10 (Truncated, aa 42-116) (25 UG) |
25 UG |
R&D SYSTEMS |
| 3210-C-025/CF |
Recombinant Mouse CCL6/C10 (Truncated, aa 42-116), CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 3214-EG-100 |
Recombinant Rat EGF (100 UG) |
100 UG |
R&D SYSTEMS |
| 3214-EG-100/CF |
Recombinant Rat EGF, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 3215-MF-050 |
Recombinant Mouse CX3CL1/Fractalkine (aa 29-102), CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 3216-RL-025 |
Recombinant Rhesus Macaque IL-12 (25 UG) |
25 UG |
R&D SYSTEMS |
| 3216-RL-025/CF |
Recombinant Rhesus Macaque IL-12, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 3217-MG-025 |
Recombinant Mouse CCL9/10MIP-1 gamma (Truncated) (25 UG) |
25 UG |
R&D SYSTEMS |
| 3217-MG-025/CF |
Recombinant Mouse CCL9/10MIP-1 gamma (Truncated), CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 3218-ND-025 |
Recombinant Human Nodal (25 UG) |
25 UG |
R&D SYSTEMS |
| 3218-ND-025/CF |
Recombinant Human Nodal, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 321-FL-050 |
Recombinant Human VEGF R1/Flt-1/Fc Chimera (50 UG) |
50 UG |
R&D SYSTEMS |
| 321-FL-050/CF |
Recombinant Human VEGF R1/Flt-1/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 3220-ZN-010 |
Recombinant Human Meprin alpha Subunit/MEP1A, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 3225-FN-100 |
Recombinant Human Fibronectin Fragment 2, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 3229-BM-010 |
Recombinant Human BMP-2/BMP-7 Heterodimer (10 UG) |
10 UG |
R&D SYSTEMS |
| 3229-BM-010/CF |
Recombinant Human BMP-2/BMP-7 Heterodimer, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 322-PR-050 |
Recombinant Human PDGF sR alpha (50 UG) |
50 UG |
R&D SYSTEMS |
| 322-PR-050/CF |
Recombinant Human PDGF sR alpha, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 3230-A5-050 |
Recombinant Human Integrin alpha 5 beta 1, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 3234-MN-050 |
Recombinant Mouse Matrilin-2 (50 UG) |
50 UG |
R&D SYSTEMS |
| 3234-MN-050/CF |
Recombinant Mouse Matrilin-2, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 3235-NF-050 |
Recombinant Rat Neurofascin, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 3236-N4-005 |
Recombinant Mouse NT-4 (5 UG) |
5 UG |
R&D SYSTEMS |
| 3236-N4-005/CF |
Recombinant Mouse NT-4, CF (5 UG) |
5 UG |
R&D SYSTEMS |
| 3237-S3-025 |
Recombinant Mouse Semaphorin 3F/Fc Chimera (Truncated), CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 3238-S3-025 |
Recombinant Mouse Semaphorin 3E/Fc Chimera, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 3239-S3-025 |
Recombinant Human Semaphorin 3E, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 3245-MP-010 |
Recombinant Rat MMP-8, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 3246-PI-010 |
Recombinant Human Latexin, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 324-HC-010 |
Recombinant Human CCL14a/HCC-1 (10 UG) |
10 UG |
R&D SYSTEMS |
| 324-HC-010/CF |
Recombinant Human CCL14a/HCC-1, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 324-HC-050 |
Recombinant Human CCL14a/HCC-1 (50 UG) |
50 UG |
R&D SYSTEMS |
| 324-HC-050/CF |
Recombinant Human CCL14a/HCC-1, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 3257-RN-025 |
Recombinant Human Relaxin-1 (25 UG) |
25 UG |
R&D SYSTEMS |
| 3257-RN-025/CF |
Recombinant Human Relaxin-1, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 3258-SL-050 |
Recombinant Human Siglec-11/Fc Chimera,CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 325-CT-200 |
Recombinant Human CTLA-4/Fc Chimera (200 UG) |
200 UG |
R&D SYSTEMS |
| 325-CT-200/CF |
Recombinant Human CTLA-4/Fc Chimera, CF (200 UG) |
200 UG |
R&D SYSTEMS |
| 326-FS-050 |
Recombinant Human Fas/TNFRSF6/Fc Chimera (50 UG) |
50 UG |
R&D SYSTEMS |
| 326-FS-050/CF |
Recombinant Human Fas (CD95)/TNFRSF6/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 327-P4-025 |
Recombinant Human CCL13/MCP-4 (25 UG) |
25 UG |
R&D SYSTEMS |
| 327-P4-025/CF |
Recombinant Human CCL13/MCP-4, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 329-MR-100 |
Recombinant Human M-CSF R/Fc Chimera (100 UG) |
100 UG |
R&D SYSTEMS |
| 329-MR-100/CF |
Recombinant Human M-CSF R/Fc Chimera, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 3300-ZN-010 |
Recombinant Mouse Meprin beta Subunit/MEP1B, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 3305-SE-010 |
Recombinant Mouse Coagulation Factor VII, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 3308-AD-050 |
Recombinant Mouse Osteoadherin, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 3326-SR-050 |
Recombinant Human SorCS3, CF |
50 µg |
R&D SYSTEMS |
| 3327-CD-050 |
Recombinant Mouse CD48/SLAMF2 (Histidine-tagged), CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 332-SR-050 |
Recombinant Human SCF sR/c-kit (50 UG) |
50 UG |
R&D SYSTEMS |
| 332-SR-050/CF |
Recombinant Human SCF sR/c-kit, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 3339-FB-025 |
Recombinant Rat FGF basic (25 UG) |
25 UG |
R&D SYSTEMS |
| 3339-FB-025/CF |
Recombinant Rat FGF basic, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 333-GC-025 |
Recombinant Human CXCL6/GCP-2 (25 UG) |
25 UG |
R&D SYSTEMS |
| 333-GC-025/CF |
Recombinant Human CXCL6/GCP-2, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 3340-EL-010 |
Recombinant Equine IL-1 beta/IL-1F2 (10 UG) |
10 UG |
R&D SYSTEMS |
| 3340-EL-010/CF |
Recombinant Equine IL-1 beta/IL-1F2, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 3344-NG-050 |
Recombinant Human Noggin/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 3345-PS-050 |
Recombinant Human PSGL-1/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 3349-SE-010 |
Recombinant Human Coagulation Factor XIV/Protein C, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 334-TK-025 |
Recombinant Human CCL25/TECK (25 UG) |
25 UG |
R&D SYSTEMS |
| 334-TK-025/CF |
Recombinant Human CCL25/TECK, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 3355-CD-050 |
Recombinant Mouse CD200/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 3356-CC-025 |
Recombinant Mouse COCO |
25 µg |
R&D SYSTEMS |
| 3356-CC-025/CF |
Recombinant Mouse COCO, CF |
25 µg |
R&D SYSTEMS |
| 3357-MN-050 |
Recombinant Mouse Matrilin-3, CF |
50 µg |
R&D SYSTEMS |
| 3357-MN-050 |
Recombinant Mouse Matrilin-3, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 335-RM-025 |
Recombinant Human CCL5/Met-RANTES (25 UG) |
25 UG |
R&D SYSTEMS |
| 335-RM-025/CF |
Recombinant Human CCL5/Met-RANTES, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 336-MD-025 |
Recombinant Human CCL22/MDC (25 UG) |
25 UG |
R&D SYSTEMS |
| 336-MD-025/CF |
Recombinant Human CCL22/MDC, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 3378-LC-050 |
Recombinant Human RBP4, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 3380-MN-050 |
Recombinant Mouse Matrilin-4, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 3384-B6-200 |
Recombinant Human EphB6/Fc Chimera, CF (200 UG) |
200 UG |
R&D SYSTEMS |
| 3385-ND-050 |
Recombinant Human Nidogen-2, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 3386-HG-025 |
Recombinant Canine HGF (25 UG) |
25 UG |
R&D SYSTEMS |
| 3386-HG-025/CF |
Recombinant Canine HGF, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 3387-PC-050 |
Recombinant Porcine CD31 (PECAM-1), CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 3388-OX-050 |
Recombinant Human OX40 TNFRSF4/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 338-AC-005 |
Recombinant Human/Mouse/Rat Activin A (5 UG) |
5 UG |
R&D SYSTEMS |
| 338-AC-005/CF |
Recombinant Human/Mouse/Rat Activin A, CF (5 UG) |
5 UG |
R&D SYSTEMS |
| 338-AC-025 |
Recombinant Human/Mouse/Rat Activin A (25 UG) |
25 UG |
R&D SYSTEMS |
| 338-AC-025/CF |
Recombinant Human/Mouse/Rat Activin A, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 339-RB-100 |
Recombinant Human Activin RIIB/Fc Chimera (NS0) (100 UG) |
100 UG |
R&D SYSTEMS |
| 339-RB-100/CF |
Recombinant Human Activin RIIB/Fc Chimera (NS0), CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 339-RBB-100 |
Recombinant Human Activin RIIB/Fc Chimera (Sf 21), CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 3409-BG-050 |
Recombinant Human beta IG-H3, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 340-R2-100 |
Recombinant Human Activin RIIA/Fc Chimera (100 UG) |
100 UG |
R&D SYSTEMS |
| 340-R2-100/CF |
Recombinant Human Activin RIIA/Fc Chimera, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 3410-UR-050 |
Recombinant Human URB, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 3414-CD-050 |
Recombinant Human CD200 R1/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 341-BR-050 |
Recombinant Human TGF-beta RII/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 342-CD-200 |
Recombinant Human CD28/Fc Chimera, CF (200 UG) |
200 UG |
R&D SYSTEMS |
| 3431-005-02 |
Cultrex PathClear BME Reduced Growth Factor - Phenol Red |
5 mL |
R&D SYSTEMS |
| 3431-005-02 |
Cultrex PathClear BME Reduced Growth Factor - Phenol Red |
5 mL |
R&D SYSTEMS |
| 3431-010-02 |
Cultrex PathClear BME Reduced Growth Factor - Phenol Red |
10 mL |
R&D SYSTEMS |
| 3431-010-02 |
Cultrex PathClear BME Reduced Growth Factor - Phenol Red |
10 mL |
R&D SYSTEMS |
| 3433-005-02 |
Cultrex PathClear BME Reduced Growth Factor |
5 mL |
R&D SYSTEMS |
| 3433-010-02 |
Cultrex PathClear BME Reduced Growth Factor (2 x 5 mL) |
10 mL |
R&D SYSTEMS |
| 3436-SE-010 |
Recombinant Mouse DPP7, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 3437-ZN-010 |
Recombinant Mouse ACE-2, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 3438-SE-010 |
Recombinant Human DPP7, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 3439-ZN-010 |
Recombinant Human THOP1, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 343-E2-025 |
Recombinant Human CCL24/Eotaxin-2/MPIF-2 (25 UG) |
25 UG |
R&D SYSTEMS |
| 343-E2-025/CF |
Recombinant Human CCL24/Eotaxin-2/MPIF-2, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 3449-AM-050 |
Recombinant Human AMICA/Fc Chimera, CF |
50 µg |
R&D SYSTEMS |
| 344-ER-050 |
Recombinant Human EGF R/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 3457-SR-050 |
Recombinant Human SorCS1, CF |
50 µg |
R&D SYSTEMS |
| 3459-FZ-050 |
Recombinant Human Frizzled-10/Fc Chimera, CF |
50 µg |
R&D SYSTEMS |
| 345-FG-025 |
Recombinant Human FGF-10 (25 UG) |
25 UG |
R&D SYSTEMS |
| 345-FG-025/CF |
Recombinant Human FGF-10, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 3466-PI-010 |
Recombinant Human APP/Protease Nexin II, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 3467-MP-010 |
Recombinant Mouse MMP-12, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 346-E3-025 |
Recombinant Human CCL26/Eotaxin-3 (aa 24-94) (25 UG) |
25 UG |
R&D SYSTEMS |
| 346-E3-025/CF |
Recombinant Human CCL26/Eotaxin-3 (aa 24-94), CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 3476-LC-050 |
Recombinant Mouse RBP4, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 347-DR-100 |
Recombinant Human TRAIL R1/TNFRSF10A/Fc Chimera (100 UG) |
100 UG |
R&D SYSTEMS |
| 347-DR-100/CF |
Recombinant Human TRAIL R1/TNFRSF10A/Fc Chimera, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 3485-AN-050 |
Recombinant Human Angiopoietin-like 4, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 348-RB-050 |
Recombinant Human ErbB3/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 3495-LR-050 |
Recombinant Human LRIG3, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 3497-NR-025 |
Recombinant Mouse Norrin (25 UG) |
25 UG |
R&D SYSTEMS |
| 3497-NR-025/CF |
Recombinant Mouse Norrin, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 349-F4-050 |
Recombinant Human VEGF R3/Flt-4/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 3508-LC-050 |
Recombinant Rat Lipocalin-2/NGAL, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 350-NS-010/CF |
Recombinant Human/Rhesus Macaque/Feline CXCL12/SDF-1a, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 350-NS-050/CF |
Recombinant Human/Rhesus Macaque/Feline CXCL12/SDF-1a, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 3514-2B-050 |
Recombinant Mouse 2B4/CD244/SLAMF4/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 3515-NG-050 |
Recombinant Human Nogo-A (aa 566-748)/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 3516-FL-050 |
Recombinant Human VEGF R1/Flt-1 (aa 27-328)/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 3519-S4-050 |
Recombinant Human IGSF4, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 351-FS-010 |
Recombinant Human/Feline CXCL12/SDF-1 beta (aa 22-93) (10 UG) |
10 UG |
R&D SYSTEMS |
| 351-FS-010/CF |
Recombinant Human/Feline CXCL12/SDF-1 beta (aa 22-93), CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 351-FS-050 |
Recombinant Human/Feline CXCL12/SDF-1 beta (aa 22-93) (50 UG) |
50 UG |
R&D SYSTEMS |
| 351-FS-050/CF |
Recombinant Human/Feline CXCL12/SDF-1 beta (aa 22-93), CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 3520-AR-050 |
Recombinant Human Apolipoprotein E R2, CF |
50 µg |
R&D SYSTEMS |
| 3520-AR-050 |
Recombinant Human Apolipoprotein E R2, CF |
50 µg |
R&D SYSTEMS |
| 3525-PR-050 |
Recombinant Mouse PILR-beta, CF |
50 µg |
R&D SYSTEMS |
| 352-MS-010 |
Recombinant Human MSP (10 UG) |
10 UG |
R&D SYSTEMS |
| 352-MS-010/CF |
Recombinant Human MSP, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 352-MS-050 |
Recombinant Human MSP (50 UG) |
50 UG |
R&D SYSTEMS |
| 352-MS-050/CF |
Recombinant Human MSP, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 3537-ZN-010 |
Recombinant Human Methionine Aminopeptidase 1, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 3548-F2-050 |
Recombinant Human OSF-2/Periostin, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 354-BP-010 |
Recombinant Human BMP-7 (10 UG) |
10 UG |
R&D SYSTEMS |
| 354-BP-010/CF |
Recombinant Human BMP-7, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 3557-AH-010 |
Recombinant Human ASAH2, CF |
10 µg |
R&D SYSTEMS |
| 3557-AH-010 |
Recombinant Human ASAH2, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 3558-AH-010 |
Recombinant Mouse ASAH2, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 3559-GH-010 |
Recombinant Human Chitotriosidase/CHIT1, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 355-BEC-010 |
Recombinant Human BMP-2 (E. coli-expressed) (10 UG) |
10 UG |
R&D SYSTEMS |
| 355-BEC-010/CF |
Recombinant Human BMP-2 (E. coli-expressed), CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 355-BM-010 |
Recombinant Human BMP-2 (10 UG) |
10 UG |
R&D SYSTEMS |
| 355-BM-010/CF |
Recombinant Human BMP-2, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 3560-ZN-010 |
Recombinant Human Cytosol Nonspecific Dipeptidase/CNDP2, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 3564-DC-010 |
Recombinant Human Dopa Decarboxylase/DDC, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 3565-SE-010 |
Recombinant Mouse Trypsin 3/PRSS3, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 356-HV-100 |
Recombinant Human HVEM/TNFRSF14/Fc Chimera (100 UG) |
100 UG |
R&D SYSTEMS |
| 356-HV-100/CF |
Recombinant Human HVEM/TNFRSF14/Fc Chimera, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 357-KD-050 |
Recombinant Human VEGF R2/KDR/Fc Chimera (50 UG) |
50 UG |
R&D SYSTEMS |
| 357-KD-050/CF |
Recombinant Human VEGF R2/KDR/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 3586-SE-010 |
Recombinant Human Trypsin 2/PRSS2, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 3587-ZN-010 |
Recombinant Human Carboxypeptidase E/CPE, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 3589-CA-100 |
Recombinant Human Cyclophilin A (aa 1-165), CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 358-MT-100 |
Recombinant Human HGF R/c-MET/Fc Chimera (100 UG) |
100 UG |
R&D SYSTEMS |
| 358-MT-100/CF |
Recombinant Human HGF R/c-MET/Fc Chimera, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 3596-RN-025 |
Recombinant Human Relaxin-2 (25 UG) |
25 UG |
R&D SYSTEMS |
| 3596-RN-025/CF |
Recombinant Human Relaxin-2, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 3597-RG-050 |
Recombinant Mouse RGM-B, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 359-EA-200 |
Recombinant Human Ephrin-A3/Fc Chimera, CF (200 UG) |
200 UG |
R&D SYSTEMS |
| 360-MP-025 |
Recombinant Human CCL20/MIP-3 alpha (25 UG) |
25 UG |
R&D SYSTEMS |
| 360-MP-025/CF |
Recombinant Human CCL20/MIP-3 alpha, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 361-MI-025 |
Recombinant Human CCL19/MIP-3 beta (25 UG) |
25 UG |
R&D SYSTEMS |
| 361-MI-025/CF |
Recombinant Human CCL19/MIP-3 beta, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 3620-PI-010 |
Recombinant Mouse Latexin, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 3624-FN-050 |
Recombinant Human Fibronectin Fragment 4, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 3625-IL-010 |
Recombinant Human IL-33 (10 UG) |
10 UG |
R&D SYSTEMS |
| 3625-IL-010/CF |
Recombinant Human IL-33, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 3626-ML-010 |
Recombinant Mouse IL-33 (10 UG) |
10 UG |
R&D SYSTEMS |
| 3626-ML-010/CF |
Recombinant Mouse IL-33, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 3627-GP-050 |
Recombinant Human GPVI, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 3628-PC-050 |
Recombinant Mouse CD31/PECAM-1, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 3629-SL-050 |
Recombinant Mouse Slit3, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 362-CX-025 |
Recombinant Human CX3CL1/Fractalkine (Chemokine Domain) (25 UG) |
25 UG |
R&D SYSTEMS |
| 362-CX-025/CF |
Recombinant Human CX3CL1/Fractalkine (Chemokine Domain), CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 3630-RG-050 |
Recombinant Human RGM-B, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 3634-RG-050 |
Recombinant Mouse RGM-C, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 3636-CM-050 |
Recombinant Mouse CMG-2 (50 UG) |
50 UG |
R&D SYSTEMS |
| 3636-CM-050/CF |
Recombinant Mouse CMG-2, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 363-MG-025 |
Recombinant Human CCL15/MIP-1 delta/LKN-1 (92 aa) (25 UG) |
25 UG |
R&D SYSTEMS |
| 363-MG-025/CF |
Recombinant Human CCL15/MIP-1 delta/LKN-1 (92 aa), CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 3644-CD-050 |
Recombinant Human CD48/SLAMF2, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 3645-S2-025 |
Recombinant Human Stabilin-2 (aa 2198-2295) |
25 µg |
R&D SYSTEMS |
| 3645-S2-025 |
Recombinant Human Stabilin-2 (aa 2198-2295) (25 UG) |
25 UG |
R&D SYSTEMS |
| 3645-S2-025/CF |
Recombinant Human Stabilin-2 (aa 2198-2295), CF |
25 µg |
R&D SYSTEMS |
| 3645-S2-025/CF |
Recombinant Human Stabilin-2 (aa 2198-2295), CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 3647-TK-050 |
Recombinant Human Notch-1/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 364-DN-025 |
Recombinant Human CCL17/TARC (25 UG) |
25 UG |
R&D SYSTEMS |
| 364-DN-025/CF |
Recombinant Human CCL17/TARC, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 365-FR-025 |
Recombinant Human CX3CL1/Fractalkine (full length) (25 UG) |
25 UG |
R&D SYSTEMS |
| 365-FR-025/CF |
Recombinant Human CX3CL1/Fractalkine (full length), CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 3660-CD-050 |
Recombinant Human CD44/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 366-6C-025 |
Recombinant Human CCL21/6Ckine (25 UG) |
25 UG |
R&D SYSTEMS |
| 366-6C-025/CF |
Recombinant Human CCL21/6Ckine, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 3678-S4-050 |
Recombinant Human IGSF4B, CF |
50 µg |
R&D SYSTEMS |
| 367-NR-050 |
Recombinant Human NGF R/TNFRSF16/Fc Chimera (50 UG) |
50 UG |
R&D SYSTEMS |
| 367-NR-050/CF |
Recombinant Human NGF R/TNFRSF16/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 3687-CR-050 |
Recombinant Mouse CRTAM/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 3688-LR-050 |
Recombinant Mouse LRIG1, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 3689-TM-050 |
Recombinant Rat TIM-1/KIM-1/HAVCR, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 368-ST-050 |
Recombinant Human Flt-3/Flk-2/Fc Chimera (50 UG) |
50 UG |
R&D SYSTEMS |
| 368-ST-050/CF |
Recombinant Human Flt-3/Flk-2/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 369-EA-200 |
Recombinant Human Ephrin-A4/Fc Chimera, CF (200 UG) |
200 UG |
R&D SYSTEMS |
| 370-AL-100 |
Recombinant Human ALK-1/Fc Chimera, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 3710-SE-010 |
Recombinant Human Trypsin 3/PRSS3, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 3714-SE-010 |
Recombinant Human Active Trypsin 3/PRSS3, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 3715-SE-010 |
Recombinant Human FAP, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 3718-FB-01M |
Recombinant Human FGF basic (145 aa), CF (1 MG) |
1 MG |
R&D SYSTEMS |
| 371-MP-025 |
Recombinant Human CCL23/MPIF-1 (25 UG) |
25 UG |
R&D SYSTEMS |
| 371-MP-025/CF |
Recombinant Human CCL23/MPIF-1, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 3720-RG-050 |
Recombinant Human RGM-C, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 3724-NR-050 |
Recombinant Mouse CAR/NR1I3/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 3725-RB-050 |
Recombinant Mouse Activin RIIB/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 3726-AG-100 |
Recombinant Human AgRP C-Terminal Fragment, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 3727-BP-010 |
Recombinant Human BMP-4/BMP-7 Heterodimer (10 UG) |
10 UG |
R&D SYSTEMS |
| 3727-BP-010/CF |
Recombinant Human BMP-4/BMP-7 Heterodimer, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 3728-NG-050 |
Recombinant Rat Nogo-A/Fc Chimera (aa 1026-1090), CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 372-RI-050 |
Recombinant Human TNF RI/TNFRSF1A/Fc Chimera (50 UG) |
50 UG |
R&D SYSTEMS |
| 372-RI-050/CF |
Recombinant Human TNF RI/TNFRSF1A/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 3735-NT-050 |
Recombinant Human Notch-2/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 373-TC-050 |
Recombinant Human TrkC/Fc Chimera (50 UG) |
50 UG |
R&D SYSTEMS |
| 373-TC-050/CF |
Recombinant Human TrkC/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 3747-CL-025 |
Recombinant Canine IL-1 beta/IL-1F2 (25 UG) |
25 UG |
R&D SYSTEMS |
| 3747-CL-025/CF |
Recombinant Canine IL-1 beta/IL-1F2, cf (25 UG) |
25 UG |
R&D SYSTEMS |
| 374-EA-200 |
Recombinant Human Ephrin-A5/Fc Chimera, CF (200 UG) |
200 UG |
R&D SYSTEMS |
| 375-TEC-010 |
Recombinant Human TRAIL/TNFSF10 (E. coli-expressed) (10 UG) |
10 UG |
R&D SYSTEMS |
| 375-TEC-010/CF |
Recombinant Human TRAIL/TNFSF10 (E. coli-expressed), CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 375-TL-010 |
Recombinant Human TRAIL/TNFSF10 (10 UG) |
10 UG |
R&D SYSTEMS |
| 375-TL-010/CF |
Recombinant Human TRAIL/TNFSF10, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 376-CT-025 |
Recombinant Human CCL27/CTACK (25 UG) |
25 UG |
R&D SYSTEMS |
| 376-CT-025/CF |
Recombinant Human CCL27/CTACK, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 3777-FK-100 |
Recombinant Human FKBP12, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 377-HB-050 |
Recombinant Human NRG1-beta 1/HRG1-beta 1 ECD (50 UG) |
50 UG |
R&D SYSTEMS |
| 377-HB-050/CF |
Recombinant Human NRG1-beta 1/HRG1-beta 1 ECD, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 3780-PS-050 |
Recombinant Human PSP94, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 378-SM-025 |
Recombinant Human NRG1 Isoform SMDF (25 UG) |
25 UG |
R&D SYSTEMS |
| 378-SM-025/CF |
Recombinant Human NRG1 Isoform SMDF, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 3795-ZN-020 |
Recombinant Human Methionine Aminopeptidase 2, CF (20 UG) |
20 UG |
R&D SYSTEMS |
| 3796-SE-010 |
Recombinant Human Tryptase beta-2, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 3814-ZN-010 |
Recombinant Human Neurolysin, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 3815-ZN-010 |
Recombinant Human Aminopeptidase N/ANPEP, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 3816-CE-010 |
Recombinant Canine Erythropoietin (10 UG) |
10 UG |
R&D SYSTEMS |
| 3816-CE-010/CF |
Recombinant Canine Erythropoietin, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 3817-AV-050 |
Recombinant Human Integrin alpha V beta 6, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 3818-MR-050 |
Recombinant Mouse M-CSF R/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 3819-FR-025 |
Recombinant Feline CCL5/RANTES (25 UG) |
25 UG |
R&D SYSTEMS |
| 3819-FR-025/CF |
Recombinant Feline CCL5/RANTES, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 381-GR-050 |
Recombinant Human G-CSF sR/CD114 (50 UG) |
50 UG |
R&D SYSTEMS |
| 381-GR-050/CF |
Recombinant Human G-CSF sR/CD114, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 3820-MR-025 |
Recombinant Mouse Reelin |
25 µg |
R&D SYSTEMS |
| 3820-MR-025 |
Recombinant Mouse Reelin (25 UG) |
25 UG |
R&D SYSTEMS |
| 3820-MR-025/CF |
Recombinant Mouse Reelin, CF |
25 µg |
R&D SYSTEMS |
| 3820-MR-025/CF |
Recombinant Mouse Reelin, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 3829-AN-050 |
Recombinant Human Angiopoietin-like 3, CF |
50 µg |
R&D SYSTEMS |
| 382-CD-100 |
Recombinant Human CD27/TNFRSF7/Fc Chimera, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 3830-ZN-010 |
Recombinant Human Aminopeptidase LRAP/ERAP2, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 383-CD-050 |
Recombinant Human CD14 (50 UG) |
50 UG |
R&D SYSTEMS |
| 383-CD-050/CF |
Recombinant Human CD14, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 3845-F5-050 |
Recombinant Human Complement Factor H-related 5/CFHR5, CF |
50 µg |
R&D SYSTEMS |
| 3845-F5-050 |
Recombinant Human Complement Factor H-related 5/CFHR5, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 3848-SE-010 |
Recombinant Human Trypsin 1/PRSS1, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 384-RG-050 |
Recombinant Human Common gamma Chain (50 UG) |
50 UG |
R&D SYSTEMS |
| 384-RG-050/CF |
Recombinant Human Common gamma Chain, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 385-PR-100 |
Recombinant Human PDGF R beta/Fc Chimera (100 UG) |
100 UG |
R&D SYSTEMS |
| 385-PR-100/CF |
Recombinant Human PDGF R beta/Fc Chimera, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 3865-TR-050 |
Recombinant Human Tenascin R, CF |
50 µg |
R&D SYSTEMS |
| 3865-TR-050 |
Recombinant Human Tenascin R, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 3867-FG-025 |
Recombinant Human FGF-22 (25 UG) |
25 UG |
R&D SYSTEMS |
| 3867-FG-025/CF |
Recombinant Human FGF-22, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 3868-AV-050 |
Recombinant Human Integrin alpha L beta 2, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 3870-N1-025 |
Recombinant Human Neuropilin-1, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 3874-T2-100 |
Recombinant Rat Tie-2/Fc Chimera, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 387-NE-025 |
Recombinant Human Neurturin (Histidine-tagged) (25 UG) |
25 UG |
R&D SYSTEMS |
| 387-NE-025/CF |
Recombinant Human Neurturin (Histidine-tagged), CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 3894-PA-010 |
Recombinant Mouse Thrombomodulin/CD141, CF |
10 µg |
R&D SYSTEMS |
| 389-LR-100 |
Recombinant Human Leptin R/Fc Chimera (100 UG) |
100 UG |
R&D SYSTEMS |
| 389-LR-100/CF |
Recombinant Human Leptin R/Fc Chimera, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 390-TN-010 |
Recombinant Human TRANCE/RANK L/TNFSF11 (Truncated) (10 UG) |
10 UG |
R&D SYSTEMS |
| 390-TN-010/CF |
Recombinant Human TRANCE/RANK L/TNFSF11 (Truncated), CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 391-GR-050 |
Recombinant Human IGF-I sR,(IGF-1 sR), CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 392-MG-010 |
Recombinant Human CXCL9/MIG (10 UG) |
10 UG |
R&D SYSTEMS |
| 392-MG-010/CF |
Recombinant Human CXCL9/MIG, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 392-MG-050 |
Recombinant Human CXCL9/MIG (50 UG) |
50 UG |
R&D SYSTEMS |
| 392-MG-050/CF |
Recombinant Human CXCL9/MIG, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 3934-CM-050 |
Recombinant Human CEACAM-6/CD66c, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 3937-EC-050 |
Recombinant Human ECM-1, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 3938-FN-050 |
Recombinant Human Fibronectin Fragment 3, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 3939-FA-050 |
Recombinant Human FCAR/CD89, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 393-NP-010 |
Recombinant Human CXCL7/NAP-2 (10 UG) |
10 UG |
R&D SYSTEMS |
| 393-NP-010/CF |
Recombinant Human CXCL7/NAP-2, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 393-NP-050 |
Recombinant Human CXCL7/NAP-2 (50 UG) |
50 UG |
R&D SYSTEMS |
| 393-NP-050/CF |
Recombinant Human CXCL7/NAP-2, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 3940-TS-050 |
Recombinant Human TSK, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 3944-ED-010 |
Recombinant Human Ectodysplasin (EDA) (10 UG) |
10 UG |
R&D SYSTEMS |
| 3944-ED-010/CF |
Recombinant Human Ectodysplasin (EDA), CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 3946-SE-010 |
Recombinant Human Matriptase/ST14 Catalytic Domain, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 3947-PA-010 |
Recombinant Human Thrombomodulin/CD141, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 3948-AP-010 |
Recombinant Human TRACP/PAP/ACP5, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 394-PA-010 |
Recombinant Human CCL18/PARC (10 UG) |
10 UG |
R&D SYSTEMS |
| 394-PA-010/CF |
Recombinant Human CCL18/PARC, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 394-PA-050 |
Recombinant Human CCL18/PARC (50 UG) |
50 UG |
R&D SYSTEMS |
| 394-PA-050/CF |
Recombinant Human CCL18/PARC, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 3956-BP-050 |
Recombinant Human BMP-10 Propeptide, CF |
50 µg |
R&D SYSTEMS |
| 395-EB-200 |
Recombinant Human Ephrin-B3/Fc Chimera, CF (200 UG) |
200 UG |
R&D SYSTEMS |
| 3968-CD-050 |
Recombinant Human CD99/Fc Chimera, CF |
50 µg |
R&D SYSTEMS |
| 396-HB-050 |
Recombinant Human NRG1-beta 1/HRG1-beta 1 EGF Domain (50 UG) |
50 UG |
R&D SYSTEMS |
| 396-HB-050/CF |
Recombinant Human NRG1-beta 1/HRG1-beta 1 EGF Domain, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 397-TR-050 |
Recombinant Human TrkB (50 UG) |
50 UG |
R&D SYSTEMS |
| 397-TR-050/CF |
Recombinant Human TrkB, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 3986-NT-050 |
Recombinant Mouse NTB-A/SLAMF6, CF |
50 µg |
R&D SYSTEMS |
| 3986-NT-050 |
Recombinant Mouse NTB-A/SLAMF6, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 398-LP-01M |
Recombinant Human Leptin, CF (1 MG) |
1 MG |
R&D SYSTEMS |
| 398-LP-05M |
Recombinant Human Leptin, CF (5 MG) |
5 MG |
R&D SYSTEMS |
| 4007-ZN-010 |
Recombinant Mouse Meprin alpha Subunit/MEP1A, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 4008-ZN-010 |
Recombinant Human Leukotriene A4 Hydrolase/LTA4H, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 4009-BC-050 |
Recombinant Human Brevican, CF |
50 µg |
R&D SYSTEMS |
| 400-ML-005 |
Recombinant Mouse IL-1 alpha/IL-1F1 (5 UG) |
5 UG |
R&D SYSTEMS |
| 400-ML-005/CF |
Recombinant Mouse IL-1 alpha/IL-1F1, CF (5 UG) |
5 UG |
R&D SYSTEMS |
| 400-ML-025 |
Recombinant Mouse IL-1 alpha/IL-1F1 (25 UG) |
25 UG |
R&D SYSTEMS |
| 400-ML-025/CF |
Recombinant Mouse IL-1 alpha/IL-1F1, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 4010-DK-010 |
Recombinant Rat Dkk-1 (10 UG) |
10 UG |
R&D SYSTEMS |
| 4010-DK-010/CF |
Recombinant Rat Dkk-1, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 4014-SP-050 |
Recombinant Human IBSP/Sialoprotein II, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 4015-AB-050 |
Recombinant Human IFN-alpha/beta R2/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 4016-LR-050 |
Recombinant Mouse LAIR1, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 4017-TR-025 |
Recombinant Canine sTNF RI/TNFRSF1A |
25 µg |
R&D SYSTEMS |
| 4017-TR-025/CF |
Recombinant Canine sTNF RI/TNFRSF1A, CF |
25 µg |
R&D SYSTEMS |
| 4017-TR-050 |
Recombinant Canine sTNF RI/TNFRSF1A (50 UG) |
50 UG |
R&D SYSTEMS |
| 4017-TR-050/CF |
Recombinant Canine sTNF RI/TNFRSF1A, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 401-ML-005 |
Recombinant Mouse IL-1 beta/IL-1F2 (5 UG) |
5 UG |
R&D SYSTEMS |
| 401-ML-005/CF |
Recombinant Mouse IL-1 beta/IL-1F2, CF (5 UG) |
5 UG |
R&D SYSTEMS |
| 401-ML-025 |
Recombinant Mouse IL-1 beta/IL-1F2 (25 UG) |
25 UG |
R&D SYSTEMS |
| 401-ML-025/CF |
Recombinant Mouse IL-1 beta/IL-1F2, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 402-ML-020 |
Recombinant Mouse IL-2 (20 UG) |
20 UG |
R&D SYSTEMS |
| 402-ML-020/CF |
Recombinant Mouse IL-2, CF (20 UG) |
20 UG |
R&D SYSTEMS |
| 402-ML-100 |
Recombinant Mouse IL-2 (100 UG) |
100 UG |
R&D SYSTEMS |
| 402-ML-100/CF |
Recombinant Mouse IL-2, CF (100 UG) |
100 UG |
R&D SYSTEMS |
| 403-ML-010 |
Recombinant Mouse IL-3 (10 UG) |
10 UG |
R&D SYSTEMS |
| 403-ML-010/CF |
Recombinant Mouse IL-3, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 403-ML-050 |
Recombinant Mouse IL-3 (50 UG) |
50 UG |
R&D SYSTEMS |
| 403-ML-050/CF |
Recombinant Mouse IL-3, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 4047-AM-050 |
Recombinant Human Integrin alpha M beta 2, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 404-ML-010 |
Recombinant Mouse IL-4 (10 UG) |
10 UG |
R&D SYSTEMS |
| 404-ML-010/CF |
Recombinant Mouse IL-4, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 404-ML-050 |
Recombinant Mouse IL-4 (50 UG) |
50 UG |
R&D SYSTEMS |
| 404-ML-050/CF |
Recombinant Mouse IL-4, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 405-ML-005 |
Recombinant Mouse IL-5 (5 UG) |
5 UG |
R&D SYSTEMS |
| 405-ML-005/CF |
Recombinant Mouse IL-5, CF (5 UG) |
5 UG |
R&D SYSTEMS |
| 405-ML-025 |
Recombinant Mouse IL-5 (25 UG) |
25 UG |
R&D SYSTEMS |
| 405-ML-025/CF |
Recombinant Mouse IL-5, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 4067-GP-050 |
Recombinant Human GPIb alpha, CF |
50 µg |
R&D SYSTEMS |
| 406-ML-005 |
Recombinant Mouse IL-6 (5 UG) |
5 UG |
R&D SYSTEMS |
| 406-ML-005/CF |
Recombinant Mouse IL-6, CF (5 UG) |
5 UG |
R&D SYSTEMS |
| 406-ML-025 |
Recombinant Mouse IL-6 (25 UG) |
25 UG |
R&D SYSTEMS |
| 406-ML-025/CF |
Recombinant Mouse IL-6, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 407-ML-005 |
Recombinant Mouse IL-7 (5 UG) |
5 UG |
R&D SYSTEMS |
| 407-ML-005/CF |
Recombinant Mouse IL-7, CF (5 UG) |
5 UG |
R&D SYSTEMS |
| 407-ML-025 |
Recombinant Mouse IL-7 (25 UG) |
25 UG |
R&D SYSTEMS |
| 407-ML-025/CF |
Recombinant Mouse IL-7, CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 4090-AS-020 |
Recombinant Human Renin, CF (20 UG) |
20 UG |
R&D SYSTEMS |
| 4095-EG-025 |
Recombinant Mouse Pro-EGF (aa 1-1029) (25 UG) |
25 UG |
R&D SYSTEMS |
| 4095-EG-025/CF |
Recombinant Mouse Pro-EGF (aa 1-1029), CF (25 UG) |
25 UG |
R&D SYSTEMS |
| 4096-MC-050 |
Recombinant Human M-Cadherin/Fc Chimera, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 4099-SE-010 |
Recombinant Human Chymase/CMA1, CF |
10 µg |
R&D SYSTEMS |
| 4099-SE-010 |
Recombinant Human Chymase/CMA1, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 409-ML-010 |
Recombinant Mouse IL-9 (10 UG) |
10 UG |
R&D SYSTEMS |
| 409-ML-010/CF |
Recombinant Mouse IL-9, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 409-ML-050 |
Recombinant Mouse IL-9 (50 UG) |
50 UG |
R&D SYSTEMS |
| 409-ML-050/CF |
Recombinant Mouse IL-9, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 410-MT-010/CF |
Recombinant Mouse TNF-alpha/TNFSF1A, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 410-MT-050/CF |
Recombinant Mouse TNF-alpha/TNFSF1A, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 410-TRNC-010 |
Recombinant Mouse TNF-alpha/TNFSF1A, Truncated Form (10 UG) |
10 UG |
R&D SYSTEMS |
| 410-TRNC-010/CF |
Recombinant Mouse TNF-alpha/TNFSF1A, Truncated Form, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 410-TRNC-050 |
Recombinant Mouse TNF-alpha/TNFSF1A, Truncated Form (50 UG) |
50 UG |
R&D SYSTEMS |
| 410-TRNC-050/CF |
Recombinant Mouse TNF-alpha/TNFSF1A, Truncated Form, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 4114-TC-01M |
Recombinant Human FGF basic, 145 aa (TC Grade), CF |
1 mg |
R&D SYSTEMS |
| 4114-TC-01M |
Recombinant Human FGF-basic, 145 aa (Tissue Culture Grade) (1 MG) |
1 MG |
R&D SYSTEMS |
| 4119-GH-010 |
Recombinant Human alpha-L-Iduronidase/IDUA, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 4128-CM-050 |
Recombinant Human CEACAM-5, CF |
50 µg |
R&D SYSTEMS |
| 4129-DM-050 |
Recombinant Human DMP-1, CF |
50 µg |
R&D SYSTEMS |
| 4129-DM-050 |
Recombinant Human DMP-1, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 4134-RL-010 |
Recombinant Rat IL-9 |
10 µg |
R&D SYSTEMS |
| 4134-RL-010 |
Recombinant Rat IL-9 (10 UG) |
10 UG |
R&D SYSTEMS |
| 4134-RL-010/CF |
Recombinant Rat IL-9, CF |
10 µg |
R&D SYSTEMS |
| 4134-RL-010/CF |
Recombinant Rat IL-9, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 4135-AV-050 |
Recombinant Human Integrin alpha V beta 8, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 4136-KR-050 |
Recombinant Human KIR3DS1/Fc Chimera,CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 4137-S4-050 |
Recombinant Human S100A4, CF |
50 µg |
R&D SYSTEMS |
| 4137-S4-050 |
Recombinant Human S100A4, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 4138-S4-050 |
Recombinant Mouse S100A4, CF |
50 µg |
R&D SYSTEMS |
| 4138-S4-050 |
Recombinant Mouse S100A4, CF (50 UG) |
50 UG |
R&D SYSTEMS |
| 4139-SE-010 |
Recombinant Bovine Enteropeptidase/Enterokinase, CF (10 UG) |
10 UG |
R&D SYSTEMS |
| 413-ML-005 |
Recombinant Mouse IL-13 (5 UG) |
5 UG |
R&D SYSTEMS |
| 413-ML-005/CF |
Recombinant Mouse IL-13, CF (5 UG) |
5 UG |
R&D SYSTEMS |
| R&D SYSTEMS 产品目录列表 page 4 >> 1 2 3 4 5 6 7 8 9 10 >>..More |
